[go: up one dir, main page]

ES8706116A1 - Un procedimiento para la preparacion de oxindol-carboxamidas triciclicas - Google Patents

Un procedimiento para la preparacion de oxindol-carboxamidas triciclicas

Info

Publication number
ES8706116A1
ES8706116A1 ES552044A ES552044A ES8706116A1 ES 8706116 A1 ES8706116 A1 ES 8706116A1 ES 552044 A ES552044 A ES 552044A ES 552044 A ES552044 A ES 552044A ES 8706116 A1 ES8706116 A1 ES 8706116A1
Authority
ES
Spain
Prior art keywords
het
formula
conh
reaction
antiinflammatory agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES552044A
Other languages
English (en)
Other versions
ES552044A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Publication of ES8706116A1 publication Critical patent/ES8706116A1/es
Publication of ES552044A0 publication Critical patent/ES552044A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/70[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicinal Preparation (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Filling Or Discharging Of Gas Storage Vessels (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE OXINDOLCARBOXAMIDAS TRICICLICAS, DE FORMULA HET-CONH-AR.COMPRENDE LA REACCION DE UN COMPUESTO DE FORMULA HET0H, CON UN ISOCIANATO DE FORMULA AR-NCOOO, EN LAS QUE HET REPRESENTA UNO DE VARIOS TIPOS DE RADICALES HETEROPOLICICLICOS Y AR ES FENILO O FENILO SUSTITUIDO. LA REACCION SE LLEVA A CABO EN UN DISOLVENTE INERTE, TAL COMO DIMETILFORMAMIDA, EN PRESENCIA DE UNA BASE, TAL COMO HIDRURO SODICO, POR MEZCLA DE LOS REACTIVOS A UNA TEMPERATURA COMPRENDIDA ENTRE C10JC Y 0JC Y POSTERIOR CALENTAMIENTO A TEMPERATURA ENTRE LA AMBIENTE Y 45JC. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS PARA EL TRATAMIENTO DE LA ARTRITIS REUMATOIDE.
ES552044A 1984-08-24 1986-02-14 Un procedimiento para la preparacion de oxindol-carboxamidas triciclicas Expired ES8706116A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1984/001371 WO1986001510A1 (en) 1984-08-24 1984-08-24 Tricyclic oxindole antiinflammatory agents

Publications (2)

Publication Number Publication Date
ES8706116A1 true ES8706116A1 (es) 1987-06-01
ES552044A0 ES552044A0 (es) 1987-06-01

Family

ID=22182243

Family Applications (2)

Application Number Title Priority Date Filing Date
ES546377A Expired ES8704497A1 (es) 1984-08-24 1985-08-23 Un procedimiento para la preparacion de oxindal-carboxamidas triciclicas.
ES552044A Expired ES8706116A1 (es) 1984-08-24 1986-02-14 Un procedimiento para la preparacion de oxindol-carboxamidas triciclicas

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES546377A Expired ES8704497A1 (es) 1984-08-24 1985-08-23 Un procedimiento para la preparacion de oxindal-carboxamidas triciclicas.

Country Status (21)

Country Link
US (1) US4695571A (es)
EP (1) EP0173520B1 (es)
JP (1) JPS6157554A (es)
KR (1) KR870001144B1 (es)
AT (1) ATE49211T1 (es)
AU (1) AU553859B2 (es)
CA (1) CA1244427A (es)
DE (1) DE3575140D1 (es)
DK (1) DK160098C (es)
EG (1) EG17287A (es)
ES (2) ES8704497A1 (es)
FI (1) FI79319C (es)
GR (1) GR852026B (es)
HU (2) HU203238B (es)
IE (1) IE58739B1 (es)
IL (1) IL76175A (es)
PH (1) PH23065A (es)
PL (2) PL147393B1 (es)
PT (1) PT81004B (es)
WO (1) WO1986001510A1 (es)
ZA (1) ZA856403B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3531678A1 (de) * 1985-09-05 1987-03-12 Boehringer Mannheim Gmbh Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPS63223492A (ja) * 1987-03-11 1988-09-16 Okawara Mfg Co Ltd 熱交換器
US5128352A (en) * 1989-01-10 1992-07-07 Pfizer Inc. Anti-inflammatory 1-heteroaryl-oxindole-3-carboxamides
WO1990008145A1 (en) * 1989-01-10 1990-07-26 Pfizer Inc. Anti-inflammatory 1-heteroaryl-3-acyl-2-oxindoles
US5300655A (en) * 1989-04-18 1994-04-05 Pfizer Inc. 2-carboxy-thiophene derivatives
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
JPH04217684A (ja) * 1990-05-30 1992-08-07 Shionogi & Co Ltd アルド−ス還元酵素阻害物質
DE4027592A1 (de) * 1990-08-31 1992-03-05 Beiersdorf Ag Neue pyrrolobenzimidazole, imidazobenzoxazinone und imidazochinolone, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen
US20030129186A1 (en) 2001-07-25 2003-07-10 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
WO2005041957A1 (en) * 2003-10-29 2005-05-12 Pfizer Products Inc. Oxindole derivatives and their use as phosphodiesterase type 2 inhibitors
CN101287411B (zh) 2005-04-28 2013-03-06 普罗秋斯生物医学公司 药物信息系统及其用途
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
DK3395372T3 (da) 2009-02-20 2022-04-19 Enhanx Biopharm Inc System til afgivelse af glutathion-baseret medikament
EP2427178B1 (en) 2009-05-06 2023-01-04 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE756447A (fr) * 1969-10-15 1971-03-22 Pfizer Oxindolecarboxamides
US3749731A (en) * 1971-07-08 1973-07-31 Warner Lambert Co 2-oxo-n-(2-thiazolyl)-3-indoline-carboxamide
US4644005A (en) * 1984-10-31 1987-02-17 Pfizer Inc. Oxindole antiinflammatory agents

Also Published As

Publication number Publication date
ZA856403B (en) 1987-04-29
IL76175A (en) 1989-08-15
AU4663785A (en) 1986-02-27
FI861704A0 (fi) 1986-04-23
PT81004B (pt) 1987-12-30
IL76175A0 (en) 1985-12-31
KR870001144B1 (ko) 1987-06-11
WO1986001510A1 (en) 1986-03-13
IE58739B1 (en) 1993-11-03
PL147395B1 (en) 1989-05-31
HU203238B (en) 1991-06-28
EP0173520B1 (en) 1990-01-03
DK160098C (da) 1991-06-24
ES8704497A1 (es) 1987-04-01
DK382685D0 (da) 1985-08-23
ES552044A0 (es) 1987-06-01
HU902020D0 (en) 1990-07-28
PL147393B1 (en) 1989-05-31
US4695571A (en) 1987-09-22
ES546377A0 (es) 1987-04-01
EP0173520A2 (en) 1986-03-05
DE3575140D1 (de) 1990-02-08
AU553859B2 (en) 1986-07-31
HUT47580A (en) 1989-03-28
FI79319C (fi) 1989-12-11
FI861704A7 (fi) 1986-04-23
PH23065A (en) 1989-03-27
CA1244427A (en) 1988-11-08
PT81004A (en) 1985-09-01
EP0173520A3 (en) 1986-05-14
GR852026B (es) 1985-12-19
DK160098B (da) 1991-01-28
EG17287A (en) 1993-02-28
JPH0450316B2 (es) 1992-08-13
KR870002143A (ko) 1987-03-30
ATE49211T1 (de) 1990-01-15
DK382685A (da) 1986-02-25
FI79319B (fi) 1989-08-31
JPS6157554A (ja) 1986-03-24
IE852081L (en) 1986-02-24
PL255089A1 (en) 1986-12-30
HU203350B (en) 1991-07-29

Similar Documents

Publication Publication Date Title
ES8706116A1 (es) Un procedimiento para la preparacion de oxindol-carboxamidas triciclicas
ES8306133A1 (es) Un procedimiento para la preparacion de oxazolidin-2,4-dionas 5-fenil y 5-naftil sustituidas.
ES8304095A1 (es) Un procedimiento para la preparacion de derivados de quinazolina.
ES8401044A1 (es) Procedimiento para preparar derivados de piridona.
ES8204428A1 (es) Procedimiento para preparar alfa-aril-1h-1,2,4-triazol-1- etanoles
AR241247A1 (es) Procedimiento para la preparacion de nuevos derivados de imidazo ¡4,5-c¿ piridina.
ES8301980A1 (es) Procedimiento para la preparacion de 8-arilalcohil-3-fenil-3-nortropanoles .
ES8305681A1 (es) Procedimiento para la obtencion de fenileteres sustituidos.
ES8306750A1 (es) Un procedimiento para la preparacion de 2-guanidino-4-heteroariltiazoles.
ES8604215A1 (es) Un procedimiento para la preparacion de derivados enol-eteres de oxicanis.
ES8604200A1 (es) Un procedimiento para la preparacion de nuevas dihidropiridinas.
ES8307824A1 (es) Un procedimiento para preparar nuevos compuestos de cefem.
ES8206527A1 (es) Procedimiento para la 5-aroilacion de esteres de acidos 1,2-dihidro-3h-pirrolo(1,2-a)pirrol-1-carboxilicos.
ES8201582A1 (es) Un procedimiento para la preparacion de derivados de triazo-lopiridazina
ES8201116A1 (es) Procedimiento para preparar derivados de 2-nitro-5-(fenoxi sustituido)-benzoilo
ES8300729A1 (es) Un procedimiento para la produccion de un derivado de pripe-razina.
ES8606381A1 (es) Un procedimiento para preparar un derivado de uridina.
ES8609323A1 (es) Un procedimiento para la preparacion de hexahidro-arilquinolizinas sustituidas.
ES8800166A1 (es) Procedimiento para la obtencion de imidazoles sustituidos
ES8301883A1 (es) Procedimiento para la preparacion de derivados de ciclohexe-no
ES8607960A1 (es) Procedimiento para preparar acidos aroil-benzofuran y benzo-tiofen-aceticos y-propionicos
ES8202000A1 (es) Procedimiento para preparar pirimidil-quinazolinas
ES8706129A1 (es) Un procedimiento para la preparacion de derivados de imidazol triciclicos
ES8701737A1 (es) Un procedimiento para la preparacion de nuevas quinazolindionas.
ES8704901A1 (es) Un procedimiento para la preparacion de arilquinolonas 7- sustituidas

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20020401